查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1529813

介入性肿瘤学市场规模、份额、趋势分析报告：按技术、按程序、按最终用途、按地区、细分市场预测，2024-2030 年

Interventional Oncology Market Size, Share & Trends Analysis Report By Technique (Ablation Therapies, Embolization Therapies), By Procedure (Tumor Ablation, Tumor Biopsy), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 210 Pages | 商品交期: 2-10个工作天内

价格

介入性肿瘤学市场趋势

预计2023年全球介入性肿瘤市场规模为40.9亿美元，预估2024年至2030年复合年增长率为10.27%。这一增长的推动因素包括癌症患病率的增加、微创手术技术的进步、老年人口的增加、对癌症早期检测的日益关注以及公众和私人对介入肿瘤学领域兴趣的增加。根据世界卫生组织（WHO）2022年2月发布的资料，2020年约有1,000万人死于癌症，占全球整体。

全球癌症发生率上升的主要原因是烟草使用、不健康饮食、饮酒、空气污染和缺乏身体活动的增加。癌症患者的快速增加给医疗保健系统带来了重大挑战，并刺激了先进解决方案的开发，以带来更好的结果和成果。介入性肿瘤学正变得越来越受欢迎，因为它提供了传统癌症治疗（如手术、放射治疗和化疗）的微创替代方案。减少患者创伤和加速復原时间的好处是推动市场成长的关键因素。

这些惊人的统计数据凸显了有效癌症治疗的迫切需求。介入性肿瘤学采用射频消融 (RFA)、经动脉化疗栓塞 (TACE) 和冷冻等微创技术，与传统手术相比具有显着优势，包括恢復时间更短、併发症发生率更低。随着全球癌症发生率的增加，预计将加速采用这些先进的介入技术来改善患者的治疗结果和生活品质。

介入肿瘤学市场的公司正在积极采取各种策略来开发先进的解决方案，旨在改善患者的治疗和照护。例如，2021年4月，Terumo成立了全球治疗介入肿瘤学团队，以实现卓越的介入性肿瘤学解决方案，目标是提高患者的生活品质和存活率。此类措施预计将促进创新解决方案的开拓，增加介入肿瘤学的采用，并推动市场成长。

此外，开发先进解决方案的努力也有所活性化，导致政府和私人组织进行了大量投资。 2023 年 6 月，皇家飞利浦宣布，飞利浦主导的IMAGIO 临床合作伙伴联盟已获得约 2,597 万美元的津贴。这笔津贴旨在支持微创癌症治疗的研究，重点是肝癌、肺癌和软组织肉瘤。这些投资对于推进介入性肿瘤学技术和改善患者治疗效果至关重要。

技术洞察

2023年，消融治疗领域占最大的市场占有率。消融疗法，包括射频、微波、冷冻和雷射消熔，由于其微创性和有效靶向肿瘤且对周围组织损伤最小的特征而越来越受欢迎。这些治疗方法是手术和放射等传统癌症治疗方法的有希望的治疗方法，可为患者提供更快的恢復时间、更少的疼痛和更少的併发症。随着癌症患者数量逐年增加，对有效、微创治疗方法的需求也不断增加。据世界卫生组织（WHO）称，癌症是全球主要死亡原因之一，预计新患者数在未来几十年将大幅增加。癌症负担的增加正在推动创新治疗方法的采用，例如消融疗法。

预计栓塞治疗领域在预测期内将出现显着的复合年增长率。栓塞疗法选择性地闭塞血管以切断肿瘤的血液供应，因其在治疗各种类型的癌症（尤其是肝癌）方面的有效性而受到认可。与传统手术方法相比，这些微创手术具有显着优势，包括更快的恢復时间、更少的併发症以及能够靶向无法手术的肿瘤。患者和医疗保健提供者对微创治疗的日益偏好也有助于市场扩张。栓塞治疗通常在门诊进行，与传统手术相比，住院时间更短，医疗费用更低，恢復更快。这些趋势与经济高效和以患者为中心的医疗解决方案的更广泛趋势一致，使栓塞成为癌症治疗的一个有吸引力的选择。

介入性肿瘤学全球市场报告细分

该报告预测了全球、区域和国家层面的收益成长，并对 2018 年至 2030 年各子区隔的最新行业趋势进行了分析。在这项研究中，Grand View Research, Inc. 根据技术、程序、应用、最终用途和地区对全球介入肿瘤学市场报告进行了细分。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章介入肿瘤学市场变数、趋势与范围

  • 市场体系展望
  • 市场动态
  • 介入性肿瘤学市场分析工具

第 4 章：介入性肿瘤学市场：技术估计与趋势分析

  • 细分仪表板
  • 全球介入性肿瘤市场技术波动分析
  • 2018-2030 年全球介入性肿瘤学市场规模与趋势分析（按技术）
  • 消融治疗
  • 栓塞治疗
  • 切片检查技术
  • 标靶治疗输送系统
  • 影像导引手术

第五章：介入性肿瘤学市场：依程序进行估计与趋势分析

  • 细分仪表板
  • 全球介入肿瘤市场的手术波动分析
  • 2018-2030 年全球介入性肿瘤学市场规模与趋势分析（按程序）
  • 肿瘤消融
  • 肿瘤切片检查
  • 血管介入
  • 安宁疗护

第 6 章：介入性肿瘤材料市场：按应用估计和趋势分析

  • 细分仪表板
  • 全球介入性肿瘤市场应用变化分析
  • 2018-2030年全球介入性肿瘤学市场规模与趋势分析（按应用）
  • 肝癌
  • 肺癌
  • 肾癌
  • 摄护腺癌
  • 乳癌
  • 其他癌症

第 7 章：介入性肿瘤学市场：最终用途的估计和趋势分析

  • 细分仪表板
  • 全球介入肿瘤市场的最终用途变化分析
  • 2018-2030 年全球介入性肿瘤学市场规模与趋势分析（依最终用途）
  • 医院
  • 专科诊所
  • 其他的

第八章介入肿瘤学市场：区域、估计和趋势分析

  • 2023 年及 2030 年按地区分類的市场占有率分析
  • 区域市场仪表板
  • 2018-2030年市场规模及预测趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第9章 竞争格局

  • 公司/竞争对手分类
  • 策略规划
  • 2023 年企业市场分析
  • 公司简介/上市公司
    • Medtronic plc
    • Boston Scientific Corporation
    • Johnson &Johnson（Ethicon）
    • Baxter International Inc.
    • Cook Medical
    • CR Bard Inc.（Acquired by BD）
    • AngioDynamics Inc.
    • Stryker Corporation
    • B. Braun Melsungen AG
    • Terumo Corporation
    • Siemens Healthineers
    • GE Healthcare
Product Code: GVR-4-68040-363-1

Interventional Oncology Market Trends

The global interventional oncology market size was estimated at USD 4.09 billion in 2023 and is projected to grow at a CAGR of 10.27% from 2024 to 2030. This growth can be attributed to the increasing prevalence of cancer, increasing technological advancements in minimally invasive procedures, growing geriatric population, rising focus on early cancer detection, and increasing public and private investments in the field of interventional oncology. There is a significant rise in the number of cancer cases globally, increasing the need for advanced solutions facilitating better cancer care According to the World Health Organization data published in February 2022, cancer accounted for around 10 million deaths in 2020, causing 1 in every 6 deaths globally.

The rising global incidence of cancer is largely attributed to increasing tobacco use, unhealthy diets, alcohol consumption, air pollution, and physical inactivity. This surge in cancer cases poses a significant challenge for healthcare systems, spurring the development of advanced solutions that offer better results and outcomes. Interventional oncology, which provides a minimally invasive alternative to traditional cancer treatments such as surgery, radiation, and chemotherapy, has become increasingly popular. Its advantages in terms of reduced patient trauma and quicker recovery times are key factors driving market growth.

These staggering statistics highlight the urgent need for effective cancer treatments. Interventional oncology, with its array of minimally invasive techniques such as radiofrequency ablation (RFA), transarterial chemoembolization (TACE), and cryoablation, offers significant advantages over traditional surgery, including reduced recovery times and lower complication rates. As the global cancer burden continues to rise, the adoption of these advanced interventional techniques is expected to accelerate, driven by their ability to improve patient outcomes and quality of life.

Companies in the interventional oncology market are actively pursuing various strategies to develop advanced solutions aimed at improving patient treatment and care. For example, in April 2021, Terumo launched its global therapeutic interventional oncology team to achieve excellence in interventional oncology solutions, with the goal of enhancing patient quality of life and survival rates. Such initiatives are expected to spur the development of innovative solutions, increasing the adoption of interventional oncology and driving market growth.

Moreover, increased efforts to develop advanced solutions have led to significant investments from both government and private organizations. In June 2023, Royal Philips announced that the Philips-coordinated IMAGIO consortium of clinical partners received a grant of approximately $25.97 million. This funding is intended to support research on minimally invasive cancer treatments, with a focus on liver cancer, lung cancer, and soft tissue sarcomas. Such investments are crucial for advancing interventional oncology technologies and improving patient outcomes.

Technique Insights

The ablation therapies segment held the largest market share in 2023. Ablation therapies, including radiofrequency, microwave, cryoablation, and laser ablation, are gaining popularity due to their minimally invasive nature and their effectiveness in targeting tumours with minimal damage to surrounding tissues. These therapies offer a promising alternative to traditional cancer treatments such as surgery and radiation, providing patients with shorter recovery times, reduced pain, and fewer complications. With an increasing number of cancer cases each year, there is a growing demand for effective and less invasive treatment options. According to the World Health Organization, cancer is one of the leading causes of death worldwide, and the number of new cases is expected to rise significantly in the coming decades. This escalating burden of cancer is propelling the adoption of innovative treatment modalities like ablation therapies.

The embolization therapies segment is anticipated to witness a significant CAGR over the forecast period. Embolization therapies, which involve the selective occlusion of blood vessels to cut off the blood supply to tumors, are increasingly recognized for their efficacy in treating various types of cancer, particularly liver cancer. These minimally invasive procedures offer significant advantages over traditional surgical approaches, including reduced recovery times, decreased complications, and the ability to target tumors that are otherwise inoperable. The growing preference for minimally invasive procedures among patients and healthcare providers is also contributing to the market's expansion. Embolization therapies are typically performed on an outpatient basis, resulting in shorter hospital stays, lower healthcare costs, and quicker recovery times compared to traditional surgery. This preference aligns with the broader trend towards cost-effective and patient-centric healthcare solutions, making embolization an attractive option for cancer treatment.

Global Interventional Oncology Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global interventional oncology market report based on technique, procedure, application, end use, and region.

  • Technique Outlook (Revenue, USD Million, 2018 - 2030)
  • Ablation Therapies

Radiofrequency Ablation (RFA)

Microwave Ablation (MWA)

Cryoablation

Laser Ablation

Irreversible Electroporation (IRE)

  • Embolization Therapies

Transarterial Chemoembolization (TACE)

Transarterial Radioembolization (TARE)

  • Biopsy Techniques

Core Needle Biopsy

Fine Needle Aspiration (FNA)

  • Targeted Therapy Delivery Systems

Drug-Eluting Beads

Radioembolization

Drug-Eluting Stents

Injectable Hydrogels and Nanoparticles

Other Targeted Therapy Systems

  • Image-Guided Procedures

Ultrasound Guidance

CT Scan Guidance

MRI Guidance

Fluoroscopy Guidance

  • Procedure Outlook (Revenue, USD Million, 2018 - 2030)
  • Tumor Ablation
  • Tumor Biopsy
  • Vascular Interventions
  • Palliative Care
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Liver Cancer
  • Lung Cancer
  • Kidney Cancer
  • Prostate Cancer
  • Breast Cancer
  • Other Cancer
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Specialty Clinics
  • Others
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America

U.S.

Canada

Mexico

  • Europe

Germany

UK

France

Italy

Spain

Denmark

Sweden

Norway

  • Asia Pacific

China

Japan

India

South Korea

Australia

Thailand

  • Latin America

Brazil

Argentina

  • MEA

South Africa

Saudi Arabia

UAE

Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Technique Segment
    • 1.2.2. Procedure Segment
    • 1.2.3. Application Segment
    • 1.2.4. End Use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Interventional Oncology Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of cancer
      • 3.2.1.2. Increasing technological advancements in minimally invasive procedures
      • 3.2.1.3. Growing geriatric population
      • 3.2.1.4. Increasing focus on early cancer detection
      • 3.2.1.5. Increasing public and private investments in the field of interventional oncology
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost associated with interventional oncology
      • 3.2.2.2. Requirement of highly skilled professionals
  • 3.3. Interventional Oncology Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Interventional Oncology Market: Technique Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Interventional Oncology Market Product & Service Movement Analysis
  • 4.3. Global Interventional Oncology Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
  • 4.4. Ablation Therapies
    • 4.4.1. Ablation Therapies market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Radiofrequency Ablation (RFA)
      • 4.4.2.1. Radiofrequency Ablation (RFA) market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Microwave Ablation (MWA)
      • 4.4.3.1. Microwave Ablation (MWA) market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Cryoablation
      • 4.4.4.1. Cryoablation market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.5. Laser Ablation
      • 4.4.5.1. Laser Ablation market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.6. Irreversible Electroporation (IRE)
      • 4.4.6.1. Irreversible Electroporation (IRE) market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Embolization Therapies
    • 4.5.1. Embolization Therapies market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Transarterial Chemoembolization (TACE)
      • 4.5.2.1. Transarterial Chemoembolzation (TACE) market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Transarterial Radioembolization (TARE)
      • 4.5.3.1. Transarterial Radioembolization (TARE) market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Biopsy Techniques
    • 4.6.1. Biopsy Techniques market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.2. Core Needle Biopsy
      • 4.6.2.1. Core Needle Biopsy market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.3. Fine Needle Aspiration (FNA)
      • 4.6.3.1. Fine Needle Aspiration (FNA) market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Targeted Therapy Delivery Systems
    • 4.7.1. Drug Delivery Systems market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.7.2. Drug-Eluting Beads
      • 4.7.2.1. Drug-Eluting Beads market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.7.3. Radioembolization
      • 4.7.3.1. Radioembolization market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.7.4. Drug-Eluting Stents
      • 4.7.4.1. Drug-Eluting Stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.7.5. Injectable Hydrogels and Nanoparticles
      • 4.7.5.1. Injectable Hydrogels and Nanoparticles market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.7.6. Other Targeted Therapy Systems
      • 4.7.6.1. Other Targeted Therapy Systems market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Image-Guided Procedures
    • 4.8.1. Image-Guided Procedures market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.8.2. Ultrasound Guidance
      • 4.8.2.1. Ultrasound Guidance market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.8.3. CT Scan Guidance
      • 4.8.3.1. CT Scan Guidance market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.8.4. MRI Guidance
      • 4.8.4.1. MRI Guidance market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.8.5. Fluoroscopy Guidance
      • 4.8.5.1. Fluoroscopy Guidance market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Interventional Oncology Market: Procedure Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Interventional Oncology Market Procedure Movement Analysis
  • 5.3. Global Interventional Oncology Market Size & Trend Analysis, by Procedure, 2018 to 2030 (USD Million)
  • 5.4. Tumor Ablation
    • 5.4.1. Tumor Ablation market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Tumor Biopsy
    • 5.5.1. Tumor Biopsy market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Vascular Interventions
    • 5.6.1. Vascular Interventions market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Palliative Care
    • 5.7.1. Palliative Care market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Interventional Oncology Materials Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Interventional Oncology Market Application Movement Analysis
  • 6.3. Global Interventional Oncology Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 6.4. Liver Cancer
    • 6.4.1. Liver Cancer market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Lung Cancer
    • 6.5.1. Lung Cancer market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Kidney Cancer
    • 6.6.1. Kidney Cancer market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Prostate Cancer
    • 6.7.1. Prostate Cancer market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Breast Cancer
    • 6.8.1. Breast Cancer market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9. Other Cancer
    • 6.9.1. Other Cancer market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Interventional Oncology Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Interventional Oncology Market End Use Movement Analysis
  • 7.3. Global Interventional Oncology Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Hospitals
    • 7.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Specialty Clinics
    • 7.5.1. Specialty Clinics market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Interventional Oncology Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2023 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 8.4. North America
    • 8.4.1. U.S.
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Competitive scenario
      • 8.4.1.3. Regulatory framework
      • 8.4.1.4. Reimbursement scenario
      • 8.4.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.2. Canada
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Competitive scenario
      • 8.4.2.3. Regulatory framework
      • 8.4.2.4. Reimbursement scenario
      • 8.4.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.3. Mexico
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Competitive scenario
      • 8.4.3.3. Regulatory framework
      • 8.4.3.4. Reimbursement scenario
      • 8.4.3.5. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. UK
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Competitive scenario
      • 8.5.1.3. Regulatory framework
      • 8.5.1.4. Reimbursement scenario
      • 8.5.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. Germany
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Competitive scenario
      • 8.5.2.3. Regulatory framework
      • 8.5.2.4. Reimbursement scenario
      • 8.5.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. France
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Competitive scenario
      • 8.5.3.3. Regulatory framework
      • 8.5.3.4. Reimbursement scenario
      • 8.5.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.4. Italy
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Competitive scenario
      • 8.5.4.3. Regulatory framework
      • 8.5.4.4. Reimbursement scenario
      • 8.5.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.5. Spain
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Competitive scenario
      • 8.5.5.3. Regulatory framework
      • 8.5.5.4. Reimbursement scenario
      • 8.5.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.6. Norway
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Competitive scenario
      • 8.5.6.3. Regulatory framework
      • 8.5.6.4. Reimbursement scenario
      • 8.5.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.7. Sweden
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Competitive scenario
      • 8.5.7.3. Regulatory framework
      • 8.5.7.4. Reimbursement scenario
      • 8.5.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.8. Denmark
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Competitive scenario
      • 8.5.8.3. Regulatory framework
      • 8.5.8.4. Reimbursement scenario
      • 8.5.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Japan
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Competitive scenario
      • 8.6.1.3. Regulatory framework
      • 8.6.1.4. Reimbursement scenario
      • 8.6.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. China
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Competitive scenario
      • 8.6.2.3. Regulatory framework
      • 8.6.2.4. Reimbursement scenario
      • 8.6.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.3. India
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Competitive scenario
      • 8.6.3.3. Regulatory framework
      • 8.6.3.4. Reimbursement scenario
      • 8.6.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.4. Australia
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Competitive scenario
      • 8.6.4.3. Regulatory framework
      • 8.6.4.4. Reimbursement scenario
      • 8.6.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.5. South Korea
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Competitive scenario
      • 8.6.5.3. Regulatory framework
      • 8.6.5.4. Reimbursement scenario
      • 8.6.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.6. Thailand
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Competitive scenario
      • 8.6.6.3. Reimbursement scenario
      • 8.6.6.4. Regulatory framework
      • 8.6.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Brazil
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Competitive scenario
      • 8.7.1.3. Regulatory framework
      • 8.7.1.4. Reimbursement scenario
      • 8.7.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. Argentina
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Competitive scenario
      • 8.7.2.3. Regulatory framework
      • 8.7.2.4. Reimbursement scenario
      • 8.7.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8. MEA
    • 8.8.1. South Africa
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Competitive scenario
      • 8.8.1.3. Regulatory framework
      • 8.8.1.4. Reimbursement scenario
      • 8.8.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.2. Saudi Arabia
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Competitive scenario
      • 8.8.2.3. Regulatory framework
      • 8.8.2.4. Reimbursement scenario
      • 8.8.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.3. UAE
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Competitive scenario
      • 8.8.3.3. Regulatory framework
      • 8.8.3.4. Reimbursement scenario
      • 8.8.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.4. Kuwait
      • 8.8.4.1. Key country dynamics
      • 8.8.4.2. Competitive scenario
      • 8.8.4.3. Regulatory framework
      • 8.8.4.4. Reimbursement scenario
      • 8.8.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2023
  • 9.4. Company Profiles/Listing
    • 9.4.1. Medtronic plc
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. Boston Scientific Corporation
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Johnson & Johnson (Ethicon)
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Baxter International Inc.
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Cook Medical
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. C.R. Bard Inc. (Acquired by BD)
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. AngioDynamics Inc.
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Stryker Corporation
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. B. Braun Melsungen AG
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Terumo Corporation
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives
    • 9.4.11. Siemens Healthineers
      • 9.4.11.1. Company overview
      • 9.4.11.2. Financial performance
      • 9.4.11.3. Product benchmarking
      • 9.4.11.4. Strategic initiatives
    • 9.4.12. GE Healthcare
      • 9.4.12.1. Company overview
      • 9.4.12.2. Financial performance
      • 9.4.12.3. Product benchmarking
      • 9.4.12.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global interventional oncology market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 4 Global interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 5 Global interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 6 Global interventional oncology market, by end use, 2018 - 2030 (USD Million)
  • Table 7 North America interventional oncology market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 9 North America interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 10 North America interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 11 North America interventional oncology market, by end use, 2018 - 2030 (USD Million)
  • Table 12 U.S. interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 13 U.S. interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 14 U.S. interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 15 U.S. interventional oncology market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Canada interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 17 Canada interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 18 Canada interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 19 Canada interventional oncology market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Mexico interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 21 Mexico interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 22 Mexico interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 23 Mexico interventional oncology market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Europe interventional oncology market, by country, 2018 - 2030 (USD Million)
  • Table 25 Europe interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 26 Europe interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 27 Europe interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 28 Europe interventional oncology market, by end use, 2018 - 2030 (USD Million)
  • Table 29 Germany interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 30 Germany interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 31 Germany interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 32 Germany interventional oncology market, by end use, 2018 - 2030 (USD Million)
  • Table 33 UK interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 34 UK interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 35 UK interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 36 UK interventional oncology market, by end use, 2018 - 2030 (USD Million)
  • Table 37 France interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 38 France interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 39 France interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 40 France interventional oncology market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Italy interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 42 Italy interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 43 Italy interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 44 Italy interventional oncology market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Spain interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 46 Spain interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 47 Spain interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 48 Spain interventional oncology market, by end use, 2018 - 2030 (USD Million)
  • Table 49 Denmark interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 50 Denmark interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 51 Denmark interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 52 Denmark interventional oncology market, by end use, 2018 - 2030 (USD Million)
  • Table 53 Sweden interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 54 Sweden interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 55 Sweden interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 56 Sweden interventional oncology market, by end use, 2018 - 2030 (USD Million)
  • Table 57 Norway interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 58 Norway interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 59 Norway interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 60 Norway interventional oncology market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific interventional oncology market, by country, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific interventional oncology market, by end use, 2018 - 2030 (USD Million)
  • Table 66 China interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 67 China interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 68 China interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 69 China interventional oncology market, by end use, 2018 - 2030 (USD Million)
  • Table 70 Japan interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 71 Japan interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 72 Japan interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 73 Japan interventional oncology market, by end use, 2018 - 2030 (USD Million)
  • Table 74 India interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 75 India interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 76 India interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 77 India interventional oncology market, by end use, 2018 - 2030 (USD Million)
  • Table 78 South Korea interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 79 South Korea interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 80 South Korea interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 81 South Korea interventional oncology market, by end use, 2018 - 2030 (USD Million)
  • Table 82 Australia interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 83 Australia interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 84 Australia interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 85 Australia interventional oncology market, by end use, 2018 - 2030 (USD Million)
  • Table 86 Thailand interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 87 Thailand interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 88 Thailand interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 89 Thailand interventional oncology market, by end use, 2018 - 2030 (USD Million)
  • Table 90 Latin America interventional oncology market, by country, 2018 - 2030 (USD Million)
  • Table 91 Latin America interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 92 Latin America interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 93 Latin America interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 94 Latin America interventional oncology market, by end use, 2018 - 2030 (USD Million)
  • Table 95 Brazil interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 96 Brazil interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 97 Brazil interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 98 Brazil interventional oncology market, by end use, 2018 - 2030 (USD Million)
  • Table 99 Argentina interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 100 Argentina interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 101 Argentina interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 102 Argentina interventional oncology market, by end use, 2018 - 2030 (USD Million)
  • Table 103 MEA interventional oncology market, by country, 2018 - 2030 (USD Million)
  • Table 104 MEA interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 105 MEA interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 106 MEA interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 107 MEA interventional oncology market, by end use, 2018 - 2030 (USD Million)
  • Table 108 South Africa interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 109 South Africa interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 110 South Africa interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 111 South Africa interventional oncology market, by end use, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia interventional oncology market, by end use, 2018 - 2030 (USD Million)
  • Table 116 UAE interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 117 UAE interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 118 UAE interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 119 UAE interventional oncology market, by end use, 2018 - 2030 (USD Million)
  • Table 120 Kuwait interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 121 Kuwait interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 122 Kuwait interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 123 Kuwait interventional oncology market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Interventional Oncology market: Market outlook
  • Fig. 5 Interventional Oncology market: Segment outlook
  • Fig. 6 Interventional Oncology market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Interventional Oncology market driver impact
  • Fig. 9 Interventional Oncology market restraint impact
  • Fig. 10 Interventional Oncology market: Technique outlook and key takeaways
  • Fig. 11 Interventional Oncology market: Technique movement analysis
  • Fig. 12 Ablation Therapies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 13 Radiofrequency Ablation (RFA) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 Microwave Ablation (MWA) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Cryoablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Laser Ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Irreversible Electroporation (IRE) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Embolization Therapies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Transarterial Chemoembolization (TACE) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Transarterial Radioembolization (TARE) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Biopsy Techniques market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Core Needle Biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Fine Needle Aspiration (FNA) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Targeted Therapy Delivery Systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Drug-Eluting Beads market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Radioembolization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Drug-Eluting Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Injectable Hydrogels and Nanoparticles market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Other Targeted Therapy Systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Image-Guided Procedures market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Ultrasound Guidance market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 CT Scan Guidance market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 MRI Guidance market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Fluoroscopy Guidance market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Interventional Oncology market: Procedure outlook and key takeaways
  • Fig. 36 Interventional Oncology market: Procedure movement analysis
  • Fig. 37 Tumor Ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Tumor Biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Vascular Interventions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Palliative Care market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Interventional Oncology market: Application outlook and key takeaways
  • Fig. 42 Interventional Oncology market: Application movement analysis
  • Fig. 43 Liver Cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Lung Cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Kidney Cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Prostate Cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Breast Cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Other Cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Interventional Oncology market: End Use outlook and key takeaways
  • Fig. 50 Interventional Oncology market: End Use movement analysis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Specialty Clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Other market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Global Interventional Oncology market: Regional outlook and key takeaways
  • Fig. 56 Global Interventional Oncology market: Regional movement analysis
  • Fig. 57 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Target Disease Prevalence
  • Fig. 61 Key country dynamics
  • Fig. 62 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 Key country dynamics
  • Fig. 99 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 100 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 101 Key country dynamics
  • Fig. 102 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 103 Key country dynamics
  • Fig. 104 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 105 Key country dynamics
  • Fig. 106 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 107 Key country dynamics
  • Fig. 108 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)